Effectiveness of Bromium 200Ch in Allergic Rhinitis

A Clinical Study on The Effectiveness of Bromium 200c in Allergic Rhinitis with Ige Assessment - NIL

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058579

Enrollment

Registered

2023-10-12

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00- Acute nasopharyngitis [common cold]

Interventions

Intervention1: Bromium200C: First dose in 10 ml 30 sized globules, 3 pills daily three times Bromium 200 C effectively reduces the IgE levels in allergic rhinitis patients. Control Intervention1: Not

Eligibility

Inclusion criteria

Inclusion criteria: Confirmed diagnosis of persistent allergic rhinitis

Exclusion criteria

Exclusion criteria: Chronic respiratory disease Cardiovascular diseases

Design outcomes

Primary

Measure	Time frame
Homoeopathic medicine Bromium 200c intervention reduces the IgE levels in the patients with symptomatic improvement will be seenTimepoint: Homoeopathic medicine Bromium 200c intervention reduces the IgE levels in the patients with symptomatic improvement will be seen within 6 months	—

Secondary

Measure	Time frame
The total quality of lifescore, individual symptom score which include any appropriate measures of nasal obstruction,runny nose, sneezing ,itching and eye symptoms.Timepoint: 24 months	—

Countries

India

Contacts

Public ContactSatheesh M Nair

Sarada Krishna Homoeopathic Medical College and Hospital

smnair.satheesh@gmail.com9447441325

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026